Certification organization and professional society for allied health personnel
Legislation affecting payment for clinical laboratory diagnostic tests, including but not limited to COVID-19 tests; Medicare Payment Advisory Commission (MedPAC) recommendations to Congress on prospective improvements to methodologies for market pricing of the Medicare Clinical Laboratory Fee Schedule under the Protecting Access to Medicare Act of 2014 (PAMA). Support funding for the Centers for Disease Control & Prevention (CDC) Advanced Molecular Detection (AMD) program; support funding for CDC's Environmental Health Laboratory to (1) generate pediatric reference intervals for clinical diagnostic testing on children and (2) harmonize clinical laboratory test results across different testing platforms; legislation establishing a regulatory framework for laboratory-developed tests (LDTs), including S. 1666, S. 2209, and H.R. 4128; support initiatives to improve clinical laboratory testing supply chains.
MMM - Medicare/Medicaid MED - Medical/Disease Research/Clinical Labs
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
MICHAEL N. MCCARTY LAW OFFICE PLLC
1050 30th Street NW, Washington, DC, 20007, US
MICHAEL N MCCARTY MICHAEL N MCCARTY